“…Production of secondary metabolites, such as antibiotics or antitumor agents, is often linked to the inherent capacity to form mycelial pellets. Subsequent cultivations in osmotically balanced media can lead to the acquisition of mutations that allow these cells to propagate without their cell wall, even in the absence of the inducing agents (i.e., penicillin and lysozyme; Innes & Allan, 2001;Leaver, Dominguez-Cuevas, Coxhead, Daniel, & Errington, 2009;Mercier, Kawai, & Errington, 2013;Errington, 2013). Treatment of mycelia with lysozyme results in the formation of protoplasts, which are identical-sized spherical cells without a cell wall used for cell fusion and plasmid transformation (Bibb, Ward, & Hopwood, 1978;Hopwood, Wright, Bibb, & Cohen, 1977).…”